Independent aftercare information
Open Field 60 organizes practical, safety-conscious information for the period beyond ibogaine treatment: medical follow-up, integration, relapse prevention, and overdose-risk preparation. Start with the aftercare planning overview for the wider frame.
What we organize
These are informational offerings, not clinical services. They are designed to help people and supportive peers identify useful questions, sequence decisions, and recognize when professional or urgent help may be needed.
Short, structured guides on follow-up, daily stability, support mapping, and transition planning. The mechanisms often discussed around ibogaine are separated from practical post-treatment decisions so uncertainty stays visible.
Plain-language prompts for comparing support options, checking practical constraints, and preparing conversations. Our independence and safety principles explain the limits of this resource and why it does not replace medical guidance.
Context for evaluating how programs describe aftercare, setting, and continuity of support. Readers considering Canadian treatment center options can use those questions as a starting point rather than as an endorsement.
Concise definitions and evidence-aware summaries for terms that can become confusing in high-stakes conversations, including a plain distinction between ibogaine’s plant context and an individual aftercare plan.
Key workflows
Use these modules to organize questions—not to self-manage symptoms or make medication changes without qualified care.
List current symptoms, medications, and follow-up needs for a qualified clinician. For a foundational overview, the National Center for Biotechnology Information’s ibogaine overview describes concerns that warrant careful clinical attention.
Identify people, routines, and settings that can make the first weeks more predictable. Questions about different treatment facility approaches may help clarify what follow-through was discussed before discharge.
Opioid tolerance can change after abstinence, which is why overdose-risk preparation belongs in an aftercare conversation. The CDC’s overdose prevention guidance explains why prevention planning matters.
Context without endorsement
Terminology changes across regions, programs, and personal accounts. A search for ibogaine information in the United States can surface mixed legal, commercial, and safety claims; this resource encourages readers to slow down and check what a claim actually means.
Terms such as “integration” are often used broadly. Here, they refer to the practical work of carrying routines, relationships, reflection, and safety planning into daily life. The general ibogaine reference overview is useful context, but it cannot determine what follow-up is appropriate for an individual.
For family members and peers, it can also help to understand the language people may use around the substance itself, including references to common ibogaine street-name terminology, without treating informal language as evidence of safety.
FAQ collection
Clear boundaries are part of safety-conscious planning.
No. Open Field 60 is an independent information resource, not a clinic or medical provider. Medical questions, symptoms, medication decisions, and urgent safety concerns need qualified clinical or emergency support.
After reduced opioid tolerance, returning to a previous dose can raise overdose risk. Planning is informational and should include practical discussion with qualified local support. The risk and safety guide keeps that planning in one place.
Integration is used here as a practical term for carrying insights, routines, relationships, and safety planning into day-to-day life after treatment. Explore the integration practice prompts as questions to consider, not instructions for care.
A practical next step
Open the roadmap for a calm, structured way to think through follow-up, support, relapse prevention, and overdose-risk preparation after ibogaine treatment.